Abstract (Word Count = 272, limit 250) Background: The proportion of hospitalizations for heart failure with preserved ejection fraction
value=0.012) and 1 year (HR=1.14; 95% CI: 1.09-1.20, p-value <0.001) compared with white patients.
Conclusions: Black, Hispanic, and Asian patients have a lower mortality risk after a HFpEF hospitalization compared with white patients. Black patients have higher readmission rates.
These differences in mortality and readmission risk based on race/ethnicity persist after adjusting for patient characteristics, SES, and hospital factors. 
Introduction
Heart failure (HF) is an increasing public health burden in the United States with an estimated 5.7 million adults self-reporting the condition in 2012 (1) . By 2030 the prevalence of HF is expected to increase 46% to over 8 million people secondary to an aging demographic nationally (2) . While reductions in ischemic heart disease have lowered the age-standardized rates of heart failure with reduced ejection fraction (HFrEF), the proportion of patients with heart failure with preserved ejection fraction (HFpEF) has increased over the last decade (3, 4) .
Prior research on the epidemiology and outcomes among HFpEF patients is limited.
Hypertension is the strongest known risk factor for HFpEF, along with age, obesity and diabetes mellitus (5, 6) . Among hospitalized Medicare HF patients, HFpEF patients have an observed lower mortality but higher readmission rate compared to HFrEF patients (7) . While adequate control of hypertension and volume status are critical to managing symptoms, effective therapies regrettably are not shown to alter the natural history of disease or improve survival for HFpEF patients (8) .
The quality of cardiovascular care for racial and ethnic minorities is known to vary (9) .
The rate of preventable hospitalizations for conditions that include HF is highest for blacks and Hispanics when compared with whites (10) . Blacks and Hispanic hospitalized with HFrEF exacerbations have a higher 30-day and 1-year readmission rates and lower 30-day and 1-year mortality rates when compared to whites (11) . There have not been comparable studies assessing outcomes in hospitalized HFpEF patients by race/ethnicity. This study reports on the differences in patient characteristics and clinical outcomes for hospitalized HFpEF patients by race/ethnic groups using the Get With The Guidelines-Heart Failure (GWTG-HF) registry linked to the Centers for Medicare and Medicaid Services (CMS) administrative data.
Methods

Cohort
Patients discharged from the GWTG-HF registry between January 1, 2006 and December 1, 2014 were screened. All patients included in GWTG-HF registry have been identified by medical providers based on clinically diagnosed HF. Inclusion in the final cohort required age ≥65, eligible for Medicare Part A and B fee for service benefit during the discharge month, and left ventricular ejection fraction (LVEF) ≥ 50% on quantitative assessment, or if not quantitative LVEF not available, qualitative assessment of normal or mild dysfunction was included. LVEF criteria were consistent with recent society guideline definitions (8, 12) . Patients were excluded if they were transferred to a hospice facility, left against medical advice, discharge disposition was unknown, or regional socioeconomic status (SES) was not available for linkage. The GWTG-HF registry was linked to CMS administrative data providing utilization of services, expenditures, and 30-day and 1-year outcomes data.
Statistical Analysis
Baseline patient and hospital characteristics were described by race/ethnic groups. Patient factors included age, gender, medical history, vital signs, body-mass index (BMI), laboratory tests (BUN, serum creatinine, serum sodium, hemoglobin, hemoglobin A1c, and lipid panel).
Hospital characteristics included region, rural location, teaching status, and size. Percentages and median interquartile ranges (IQR) were reported for categorical and continuous variables respectively. The Pearson chi-squared test was used to compare categorical variables and the Wilcoxon rank-sum tests was used to compare ordinal categorical variables or continuous variables. Standardized differences were provided between groups.
SES was linked using patient zip code geocoding to the 2015 Area Health Resource File provided through the Health Resources and Services Administration. SES variables included median household income, median home value, percentage with high school diploma, and percentage with ≥4 years of college (13) .
The primary outcomes included 30-day and 1-year mortality and readmission rates by cause. Kaplan-Meier estimates of 30-day/1-year mortality outcomes were reported across race groups and compared using log-rank tests. The cumulative incidence function of readmission outcomes at 30-day/1-year were reported across race groups and compared using Gray's test, which determines if the cumulative incidence functions are equal across treatment groups. A Cox proportional hazards model was used for 30-day and 1-year outcomes and ties were handled using the Efron method. The models were adjusted sequentially for patient and hospital characteristics followed by patient SES based on zip code (online-only Data Supplement Tables   I, II, III) . Control variables were selected based on a literature review and prior established models used in GWTG-HF (7, 11, 13) .
Patient covariates with missingness were imputed for the Cox model (online-only Data Supplement Table IV) . Missing medical histories were imputed to not present. Multiple imputation with 25 datasets were used to impute other patient covariates. Hospital characteristics were not imputed. Patient's SES variables were assigned values from census data of the year closest to the patient's year of admission. Any dollar values of previous years were adjusted to 2015 US dollars based on the Consumer Price Index.
Results
The final cohort included 53,065 patients (online-only Data Supplement Tables V, VI, VII, VIII). The average age of hospitalization was 83 for white, 77 for black, 79 for Hispanic, and 81 for Asian patients (Table 1 ). Blacks and Hispanics had a notable younger age distribution.
The proportion of females was higher among blacks in comparison to other ethnic groups.
Blacks and Hispanics had lower rates of atrial fibrillation compared to the other ethnic groups.
Blacks and Hispanics had higher rates of diabetes, hypertension, and median body-mass index.
Among blacks, Hispanics, and Asians rates of chronic renal disease and dialysis were significantly higher. Systolic blood pressure on presentation was highest among blacks, followed by Hispanics and Asians. LVEF was not considerably different between the racial/ethnic groups.
A larger proportion of blacks received treatment in teaching hospitals.
With respect to inpatient procedures, minority patients had higher rates of dialysis (Table   2 ). On discharge, blacks had generally higher rates of anti-hypertensive and diabetic medication prescription. Inpatient mortality was highest among Asian (3.44%) and white (3.01%) patients and lowest among black (1.70%) and Hispanic (2.30%) patients. Mortality at 30-days and 1-year were 5.87% and 33.10% respectively for the overall cohort with lower rates among minority patients compared with whites (Table 3 and Figure 1 ). The 30-day and 1-year all-cause readmission rates were 22.16% and 66.95% respectively for the overall cohort with higher rates among blacks and Hispanics compared to whites. Blacks had the highest readmission rate for cardiovascular and HF related primary diagnoses at 1-year.
When controlling for hospital and patient factors, black and Hispanic ethnicities were associated with lower 30-day mortality compared to whites (Table 4 , online-only Data Supplement Table IX ). Mortality at 1-year was lower as well for blacks, Hispanics, and Asians.
The lower mortality rates persisted when adjusting for patient SES for blacks and Hispanics. Allcause 30-day and 1-year readmissions were higher among blacks when compared to whites when controlling for patient, hospital, and SES variables. While Hispanics had a similar hazard ratio for all-cause readmissions at 30-days, this did not meet statistical significance across all models.
Hispanics did have a higher risk of cardiovascular and heart failure related readmissions when compared with whites that was statistically significant when controlling for patient characteristics, hospital characteristics, and regional SES. Blacks had a 12% higher hazard ratio for the composite endpoint of 1-year mortality and readmission when compared to whites in the fully adjusted model.
Discussion
This study reports the differences in HFpEF patient characteristics both short-and longterm outcomes based on race/ethnicity after an acute HF hospitalization using a large observational cohort from the GWTG-HF registry linked to CMS administrative data. HFpEF is an increasing portion of HF hospitalizations and a growing national burden. A HFpEF admission portends considerable risk of future hospitalization and mortality. The study finds that minorities generally had lower 30-day and 1-year mortality rates and higher readmission rates when compared to whites with significant differences in comorbidity burden.
Black and Hispanic HFpEF patients had higher systolic blood pressure and BMI. With respect to comorbidities, black and Hispanic patients had higher rates of diabetes, hypertension, and renal insufficiency. These findings suggest that the known risk factors for HFpEF are more prevalent among minority patients (5, 6 ). The differences in comorbidities based on race/ethnicity among HFpEF patients is consistent with the observed trends in cardiovascular risk factors among minorities nationally where the prevalence of obesity, poorly controlled hypertension, and diabetes has increased (10) . Obesity is a strong risk factor for incident HFpEF among women and especially black women (14) . Therefore, much of the current HFpEF burden may be preventable through improvements in cardiovascular risk reduction of known risk factors that predispose to left ventricular diastolic dysfunction and the HFpEF syndrome.
While post-discharge mortality is observed to be lower for black patients, the ageadjusted prevalence of HFpEF is significantly higher, and the per capita death rate for HFpEF may still be higher for black and Hispanic HFpEF patients compared to white patients (15) . The lower short-and long-term mortality among minorities may indicate differences with regards to HFpEF stage. Hospitalized minority patients may include a larger proportion of new or recent onset disease with lower rates of 30-day and 1-year mortality. Within this Medicare cohort, black HFpEF patients were 5 years younger on average at index admission than whites. Life expectancy is observed to be significantly lower among blacks with cardiovascular conditions compared to whites (16) . From the perspective of a patient's life course, we would expect minorities to have a greater risk for incident HFpEF and a shorter life expectancy secondary to the condition.
Much of the mortality hazard was reduced when adjusting for patient level factors, suggesting that objective vitals, laboratory data, and comorbidities contribute to the differences in risk based on race/ethnicity. Differences in outcomes persisted when adjusting for hospital and SES among black patients. This suggests that the adjustments for regional SES did not contribute to the observed differences in hazard between race/ethnic groups. The persistence of measured differences by race/ethnicity despite the given adjustments suggests additional factors outside of the model should be considered. Lower quality transitional and outpatient care, neighborhood deprivation, unmeasured provider bias may better explain the higher readmission risk for black patients (17). Minority patients in low-income communities face significant barriers in receiving access to quality cardiovascular care. Despite this entire cohort having access to Medicare insurance benefits, the ability to afford copayments for follow-up appointments and prescription medications may still contribute to observed disparities. Clinics in deprived neighborhoods may not have the payer mix necessary to support additional support staff, providers, and specialists required for early and frequent follow-up visits post-hospitalization.
The higher short-and long-term mortality rate among white HFpEF patients is a competing risk that potentially confounds the higher observed readmission rates for black and Hispanic patients. However, the composite endpoint of readmission and mortality remained significantly higher among blacks when compared with whites in the fully adjusted model.
Hispanics appeared to have a similarly elevated hazard for readmission risk relative to whites as black patients did, but statistical significance was not reached across all models. The smaller cohort size for Hispanics and number of events may have limited the statistical power to detect differences in the readmission hazard. Among Asians, there was a suggestion that the composite endpoint was lower compared with whites.
Previous studies reported that HFpEF patients have lower mortality rates and higher allcause readmission rates when compared to HFrEF patients (7) . A prior GWTG-HF registry study 
Limitations
The diagnosis of HFpEF was based on the assessment of LVEF and the clinical presentation of HF. The definition for HFpEF was based on the most recent society guidelines; prior studies have defined HFpEF with a LVEF as low as 40% (22). Although some guidelines recommend abnormal levels of natriuretic peptides and assessment of diastolic dysfunction or relevant structural heart disease, additional echocardiographic data are not available in the registry (8, 12) . However, the proportion of patients with a B-type natriuretic peptide >100 pg/ml or N-terminal pro b-type natriuretic peptide > 300 pg/ml was 94.0% and comparable to prior reports of the false-negative rate for natriuretic peptide in patients with clinically diagnosed HF Legend: Values are means or %. PCI = percutaneous coronary intervention, CRT-D = cardiac resynchronization therapy implantable cardioverter defibrillator, ICD = implantable cardioverter defibrillator, CRP-P = cardiac resynchronization therapy pacemaker, ACE-I = angiotensin converting enzyme inhibitors, ARB = angiotensin II receptor blocker. Legend: Values are in %. CV = cardiovascular, HF = heart failure, Legend: Model 1 adjusts for patient characteristics only, model 2 adjusts for patient and hospital characteristics, model 3 adjusts for patient, hospital characteristics and regional SES variables based on patient zip code. CI = confidence interval, HR = hazard ratio 
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